The mission of Astex Pharmaceuticals is to discover and develop novel therapeutics with a primary focus in cancer. The products we develop will be commercialized via partnerships with Otsuka subsidiaries worldwide.
Martin Buckland DPhil, MBA
President & Chief Corporate Officer
Martin Buckland was appointed President and Chief Corporate Officer of Astex Pharmaceuticals, Inc. in November 2020. He joined Astex Therapeutics Limited as Chief Business Officer in September 2004 and served as a member of the Board of Directors from July 2008 through the merger with SuperGen Inc. to create Astex Pharmaceuticals, Inc., in July 2011.
4420 Rosewood Drive
Pleasanton, CA 94588, USA